期刊文献+

阿司匹林在缺血性心血管疾病中的应用

Usefulness of Aspirin Therapy in Cardiovascular Disease
下载PDF
导出
摘要 缺血性心血管疾病将在未来成为世界第1位死亡原因,愈来愈多的循证医学证据证实,在一、二级预防缺血性心血管病中采用小剂量(75—150mg/d)阿司匹林,急性抗血栓治疗中采用负荷剂量(150—300mg/d)的阿司匹林联合氯吡格雷(75mg/d),安全有效。本文就阿司匹林在缺血性心血管疾病中的应用进行综述。 Aspirin has an important role in the secondary prevention of cardiovascular disease and lowers the rate of death, myocardial infarction and stroke. The role of aspirin in primary prevention has assessment of cardiovascular risk. There is an expanding role for the combination of aspirin and elopidogrel in the long-term management of high-risk patients. The usefulness of Aspirin therapy in cardiovascular disease was reviewed in this paper.
出处 《医学综述》 2008年第14期2188-2191,共4页 Medical Recapitulate
关键词 阿司匹林 心血管疾病 阿司匹林抵抗 Aspirin : Cardiovascular disease: Asoirin resistance
  • 相关文献

参考文献20

二级参考文献72

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2Patrono C,Bachmann F,Baigent C,et al.European Society of Cardiology.Expert consensus document on the use of antiplatelet agents.The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.Eur Heart J,2004,25:166-181. 被引量:1
  • 3Eagle KA,Guyton RA,Davidoff R,et al.American College of Cardiology.American Heart Association Task Force on Practice Guidelines.American Society for Thoracic Surgery and the Society of Thoracic Surgeons.ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).Circulation,2004,110:1168-1176. 被引量:1
  • 4Stein PD,Alpert JS,Bussey HI,et al.Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.Chest,2001,119:2205-2275. 被引量:1
  • 5Chen ZM,Jiang LX,Chen YP,et al.COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group.Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction:randomised placebo-controlled trial.Lancet,2005,366:1607-1621. 被引量:1
  • 6Patrono C,Coller B,FitzGerald GA,et al.Platelet-active drugs:the relationships among dose,effectiveness,and side effects:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126(3 Suppl):234S-264S. 被引量:1
  • 7Pearson TA,Blair SN,Daniels SR,et al.AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke:2002 Update:Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases.American Heart Association Science Advisory and Coordinating Committee.Circulation,2002,106:388-391. 被引量:1
  • 8Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304. 被引量:1
  • 9Antithrombotic Trialists' Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86. 被引量:1
  • 10Yusuf S,Zhao F,Mehta SR,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med,2001,345:494-502. 被引量:1

共引文献244

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部